FEATURED EDITORIAL
Four executives outline which industry challenges, strategic considerations, and opportunities should be top of mind as RNA therapeutics companies establish their to-do lists for 2023.
- Will ESG Be 2023’s Hottest Business Topic In Bio/Pharma?
- The Need — And Opportunity — To Develop Broad-Spectrum Antivirals
- Outsourcing Strategies For Maximizing Drug Exclusivity
- 6 Tips For Successful Drug Discovery Teamwork
- Leveraging Human Genetics To Advance Cell Therapies For Treatment Of Blood Cancers
- How To Close The Looming Life Sciences Data Storage Gap
- Rising Interest Rates Skew Risk-Return Paradigm For Life Sciences
FEATURED APPLICATION CONTENT
-
Explore a demonstration of strategic process control in terms of flow and pressure, by utilizing a depth filtration system, for effective depth filter processing and recovery of excess product.
-
Learn more about improving the performance of a scalable AAV process in Xcellerex™ XDR-10 and XDR-200 bioreactors using HyClone™ peak expression medium.
-
Cell line development is a complex, labor intensive, and multistep process. Learn about a platform and host cell line that minimize the risk and timeline to develop high-performing clones.
-
Discover a single-use automated filtration system designed to deliver robust process control and integrity assurance during the critical purification step. Explore its innovative design features, processing control, and more.
-
Explore a fill system designed to automate product draining and recovery within a batch to standardize processes and minimize non-recoverable hold-up within the filtration and distribution flow path sections.
-
Learn about a solution that can provide a simple, easy, and versatile method for capsule and depth filtration, allowing a quick, efficient move from cell harvest to purification.
-
A biotech company partnered with an integrated research, development and manufacturing services company to deliver pre-IND to IND safety studies for a treatment therapy for gut-brain diseases.
-
Many antibody variants are prone to aggregation or to forming product-related impurities. Explore the application of a resin with novel selectivity to purify challenging entities.
-
Explore the collected best methods/practices to give filter end users the best possible chance of performing a successful water intrusion test.
-
Learn how cell performance within the context of the cell line development workflow was confirmed with the successful isolation of stable, high-producing clones from three model monoclonal antibodies.
-
We describe the performance of two assays for titer analysis of adeno-associated virus (AAV), serotype 2 and serotype 5, based on surface plasmon resonance (SPR).
-
Explore how we expanded HEK293/HEK293T suspension cells from small cell culture (20 mL) in shake flasks up to a 10 L culture in a benchtop Xcellerex™ XDR-10 single-use bioreactor system.
FEATURED NEWS HEADLINES
- Syros Receives Fast Track Designation From The FDA For Tamibarotene For The Treatment Of Higher-Risk Myelodysplastic Syndrome
- Targeting Cancer With A Multidrug Nanoparticle
- Ascletis Announces IND Approval Of Oral Viral Polymerase Inhibitor ASC10 For Monkeypox Indication By China NMPA
- Poxel Receives Orphan Drug Designation From The European Commission For PXL770 And PXL065 For Treatment Of Adrenoleukodystrophy
- Disarming Pathogens: New Drug Candidates To Combat Chronic Infections
- New Enzyme Could Mean Better Drugs
- Blueprint Medicines Announces FDA Acceptance Of Supplemental New Drug Application For AYVAKIT® (avapritinib) For The Treatment Of Indolent Systemic Mastocytosis
- US FDA Accepts Supplemental New Drug Application For Jardiance® For Adults With Chronic Kidney Disease
- Mirati Announces IND Clearance By U.S. FDA Enabling Phase 1 Initiation For First-In-Class Oral KRASG12D Selective Inhibitor, MRTX1133
- UCLA Chemists Are First To Synthesize Ocean-Based Molecule That Could Fight Parkinson’s
ARCHIVED NEWSLETTER
- 01.24.23 -- Ensure Microbial Control In The Pharmaceutical Production Environment
- 01.24.23 -- Application Of A Novel Temperature Shift Process For Particle Engineering
- 01.17.23 -- Recent Innovations And Enhancements To Pharmaceutical Spray Drying
- 01.10.23 -- End-To-End Development And Manufacturing: Small Volume Commercial Products
- 01.03.23 -- The Development, Scale-Up, And Manufacturing Of Semi-Solid Dosage Forms